Picture of Athenex logo

ATNXQ — Athenex News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Athenex Announces UK MHRA Validation Of The Marketing Authorization Application For Oral Paclitaxel And Encequidar For Review

Nov 29 (Reuters) - Athenex Inc  ATNX.O :
    * ATHENEX ANNOUNCES UK MHRA VALIDATION OF THE MARKETING
AUTHORIZATION APPLICATION FOR ORAL PACLITAXEL AND ENCEQUIDAR FOR
REVIEW

Source text for Eikon:  ID:nGNX6vfx2r 
Further company coverage:  ATNX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Athenex

See all news